Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction

Nicolás Valls, Juan G. Gormaz, Rubén Aguayo, Jaime González, Roberto Brito, Daniel Hasson, Matías Libuy, Cristóbal Ramos, Rodrigo Carrasco, Juan C. Prieto, Gastón Dussaillant, Ángel Puentes, Viviana Noriega, Ramón Rodrigo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

18 Citas (Scopus)


Purpose: Percutaneous coronary angioplasty (PCA) has been demonstrated to reduce mortality and morbidity and thereby improve the prognosis of patients undergoing acute myocardial infarctions (AMIs). However, this procedure paradoxically increases the initial damage as the result of a condition known as ‘myocardial reperfusion injury’. Oxidative stress may contribute to the mechanism of this injury. The goal of the present study was to ascertain whether high plasma ascorbate levels could ameliorate the reperfusion injuries that occur after the successful restoration of blood flow. Methods: Patients from three clinical centers of the public health system were included in the study. The groups were formed by either-sex patients with a diagnosis of ST-segment elevation myocardial infarction with an indication for primary PCA. Only the patients who presented with their first myocardial infarction were enrolled. Ascorbate was administered through an infusion given prior to the restoration of the coronary flow, which was then followed by oral treatment with vitamin C (500 mg/12 hours) plus vitamin E (400 IU/day) for 84 days. The left ventricular ejection fraction (LVEF) was determined by using cardiac magnetic resonance on days 6 and 84 following the onset of the reperfusion. In addition, the microvascular function was assessed by an angiographic evaluation using the Thrombolysis In Myocardial Infarction (TIMI) myocardial perfusion grade (TMPG). The results were grouped according to the plasma ascorbate concentration achieved immediately following the onset of reperfusion into either the HA group (high ascorbate, >1 mmol/l) or the LA group (low ascorbate, <1 mmol/l). The biochemical parameters were analyzed throughout the protocol. Results: The LVEF of the HA group was significantly higher than that of the LA group, values on day 84 in the HA group were 33% higher than those of the LA group. The amelioration of the LVEF was accompanied by an improvement in the microvascular dysfunction, after PCA, 95% of the patients in the HA group achieved a TMPG of 2–3, in the LA group only 79% of patients showed a TMPG of 2–3. Conclusions: These data are consistent with the protective effect of high plasma levels of ascorbate against the oxidative challenge caused by reperfusion injury in patients subjected to PCA following an AMI. Further studies are needed to elucidate the mechanism accounting for this beneficial antioxidant effect.

Idioma originalInglés
Páginas (desde-hasta)75-83
Número de páginas9
PublicaciónRedox Report
EstadoPublicada - 3 mar. 2016

Áreas temáticas de ASJC Scopus

  • Bioquímica
  • Fisiología
  • Bioquímica clínica
  • Biología celular
  • Bioquímica médica


Profundice en los temas de investigación de 'Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction'. En conjunto forman una huella única.

Citar esto